rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2000-5-11
|
pubmed:abstractText |
Geldanamycin (GM) is a natural antibiotic that binds Hsp90 and induces the degradation of receptor tyrosine kinases, steroid receptors, and Raf. It is a potent inhibitor of cancer cells that overexpress HER-kinases, but its effects on other important proteins may cause significant toxicity and limit its clinical use. We report the synthesis and identification of a GM dimer, GMD-4c, which had selective activity against HER-kinases. Selectivity was a function of linker length and required two intact GM moieties. GMD-4c is a potent inducer of G1 block and apoptosis of breast cancer cell lines that overexpress HER2, but does not appreciably inhibit the growth of 32D cells that lack HER-kinases. GMD-4c could be useful in the treatment of carcinomas dependent on HER-kinases.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Benzoquinones,
http://linkedlifedata.com/resource/pubmed/chemical/Lactams, Macrocyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-raf,
http://linkedlifedata.com/resource/pubmed/chemical/Quinones,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, IGF Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/geldanamycin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0008-5472
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2090-4
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10786665-Antibiotics, Antineoplastic,
pubmed-meshheading:10786665-Benzoquinones,
pubmed-meshheading:10786665-Blotting, Western,
pubmed-meshheading:10786665-Breast Neoplasms,
pubmed-meshheading:10786665-Cell Division,
pubmed-meshheading:10786665-Dimerization,
pubmed-meshheading:10786665-Down-Regulation,
pubmed-meshheading:10786665-Humans,
pubmed-meshheading:10786665-Immunohistochemistry,
pubmed-meshheading:10786665-Inhibitory Concentration 50,
pubmed-meshheading:10786665-Lactams, Macrocyclic,
pubmed-meshheading:10786665-Proto-Oncogene Proteins c-raf,
pubmed-meshheading:10786665-Quinones,
pubmed-meshheading:10786665-Receptor, IGF Type 1,
pubmed-meshheading:10786665-Receptor, erbB-2,
pubmed-meshheading:10786665-Receptors, Estrogen,
pubmed-meshheading:10786665-Substrate Specificity,
pubmed-meshheading:10786665-Tumor Cells, Cultured
|
pubmed:year |
2000
|
pubmed:articleTitle |
Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases.
|
pubmed:affiliation |
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. zhengf@mskcc.org
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|